161 related articles for article (PubMed ID: 15464070)
1. Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test.
Shimazaki T; Iijima M; Chaki S
Eur J Pharmacol; 2004 Oct; 501(1-3):121-5. PubMed ID: 15464070
[TBL] [Abstract][Full Text] [Related]
2. MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.
Chaki S; Yoshikawa R; Hirota S; Shimazaki T; Maeda M; Kawashima N; Yoshimizu T; Yasuhara A; Sakagami K; Okuyama S; Nakanishi S; Nakazato A
Neuropharmacology; 2004 Mar; 46(4):457-67. PubMed ID: 14975669
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.
Pałucha-Poniewiera A; Wierońska JM; Brański P; Stachowicz K; Chaki S; Pilc A
Psychopharmacology (Berl); 2010 Dec; 212(4):523-35. PubMed ID: 20703449
[TBL] [Abstract][Full Text] [Related]
4. AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist.
Karasawa J; Shimazaki T; Kawashima N; Chaki S
Brain Res; 2005 Apr; 1042(1):92-8. PubMed ID: 15823257
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
Koike H; Iijima M; Chaki S
Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
[TBL] [Abstract][Full Text] [Related]
6. An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats.
Yoshimizu T; Shimazaki T; Ito A; Chaki S
Psychopharmacology (Berl); 2006 Jul; 186(4):587-93. PubMed ID: 16612616
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent.
Stachowicz K; Wierońska J; Domin H; Chaki S; Pilc A
Pharmacol Rep; 2011; 63(4):880-7. PubMed ID: 22001975
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
[TBL] [Abstract][Full Text] [Related]
9. A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell.
Karasawa J; Yoshimizu T; Chaki S
Neurosci Lett; 2006 Jan; 393(2-3):127-30. PubMed ID: 16233956
[TBL] [Abstract][Full Text] [Related]
10. Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential.
Yasuhara A; Nakamura M; Sakagami K; Shimazaki T; Yoshikawa R; Chaki S; Ohta H; Nakazato A
Bioorg Med Chem; 2006 Jun; 14(12):4193-207. PubMed ID: 16487713
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists.
Nakazato A; Sakagami K; Yasuhara A; Ohta H; Yoshikawa R; Itoh M; Nakamura M; Chaki S
J Med Chem; 2004 Aug; 47(18):4570-87. PubMed ID: 15317467
[TBL] [Abstract][Full Text] [Related]
12. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
Egashira N; Okuno R; Harada S; Matsushita M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 May; 586(1-3):164-70. PubMed ID: 18423440
[TBL] [Abstract][Full Text] [Related]
13. Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice.
Iijima M; Shimazaki T; Ito A; Chaki S
Psychopharmacology (Berl); 2007 Feb; 190(2):233-9. PubMed ID: 17102982
[TBL] [Abstract][Full Text] [Related]
14. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors.
Kawashima N; Karasawa J; Shimazaki T; Chaki S; Okuyama S; Yasuhara A; Nakazato A
Neurosci Lett; 2005 Apr; 378(3):131-4. PubMed ID: 15781145
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydroalcoholic extract of leaves of Colocasia esculenta on marble-burying behavior in mice: Implications for obsessive-compulsive disorder.
Kalariya M; Prajapati R; Parmar SK; Sheth N
Pharm Biol; 2015 Aug; 53(8):1239-42. PubMed ID: 25885941
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro pharmacology, and structure-activity relationships of 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as mGluR2 antagonists.
Yasuhara A; Sakagami K; Yoshikawa R; Chaki S; Nakamura M; Nakazato A
Bioorg Med Chem; 2006 May; 14(10):3405-20. PubMed ID: 16431115
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the metabolism and bioavailability of ester prodrugs of mgs0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid), a potent metabotropic glutamate receptor antagonist.
Nakamura M; Kawakita Y; Yasuhara A; Fukasawa Y; Yoshida K; Sakagami K; Nakazato A
Drug Metab Dispos; 2006 Mar; 34(3):369-74. PubMed ID: 16326817
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
